

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">

<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infert</journal-id>
      <journal-id journal-id-type="publisher-id">arij001</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">jri140186</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Comparison of Cumulative Live Birth Rate (CLBR) According to Patient Oriented Strategies Encompassing Individualized Oocyte Number (POSEIDON) Stratification Among Low Prognosis Women Undergoing IVF-ICSI Cycles</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Bansiwal</surname><given-names>Reeta</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mahey</surname><given-names>Reeta</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Malhotra</surname><given-names>Neena</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Neeta</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Saini</surname><given-names>Monika</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Bhatt</surname><given-names>Ashok</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Nilima</surname><given-names>Nilima</given-names></name></contrib><aff>Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Mani</surname><given-names>Kalaivani</given-names></name></contrib><aff>Department of Biostatistics, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Cheluvaraju</surname><given-names>Rohitha</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rajput</surname><given-names>Monika</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Bhatla</surname><given-names>Neerja</given-names></name></contrib><aff>Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences (AIIMS), New Delhi, India</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>24</volume>
      <issue>2</issue>
      <fpage>117</fpage>
      <lpage>132</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>9</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>25</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: The purpose of the current study was to evaluate patient-oriented strategies encompassing individualized oocyte number (POSEIDON) criteria, validate stratification of low prognosis women, and prognosticate their reproductive potential in terms of cumulative live birth rate (CLBR) in Indian women.&lt;br /&gt;
Methods: Out of 4048 women who underwent IVF/ICSI, 3287 women met the criteria for final evaluation of CLBR. They criteria were divided into (a) group 1a as cases with &amp;lt;4 oocytes retrieved and 1b with 4-9 oocytes retrieved; (b) group 2a as cases with &amp;lt;4 oocytes retrieved and 2b with 4-9 oocytes retrieved; (c) group 3 (&amp;lt;35 years, AMH &amp;lt;1.2 &lt;em&gt;ng/ml&lt;/em&gt;, AFC &amp;lt;5); and (d) group 4 (&amp;ge;35 years, AMH &amp;lt;1.2 &lt;em&gt;ng/ml&lt;/em&gt;, AFC &amp;lt;5). Non-POSEIDON group was sub-divided into normo-responders (10-20 oocytes) and hyper-responder (&amp;gt;20 oocytes).&lt;br /&gt;
Results: Overall CLBR was two-fold lower in POSEIDON group as compared to non-POSEIDON group (p&amp;lt;0.001). For every one-year increase in the age, the odds of CLBR decreased by 4% (OR 0.96, CI 0.93-0.99) in POSEIDON group and by 5% (OR 0.95, CI 0.92-0.98) in non-POSEIDON group. For every unit increase in number of oocytes retrieved, the odds of CLBR increased by 1.22 times (OR1.22, CI 1.16-1.28) in POSEIDON group and by 1.08 times (OR 1.08, CI 1.05-1.11) in non-POSEIDON group. Among POSEIDON groups, the highest values in CLBR belonged to group 1b followed by 3, 2b, 4, 1a, and 2a.&lt;br /&gt;
Conclusion: POSEIDON stratification of low-prognosis women undergoing IVF may be considered valid to prognosticate and counsel women undergoing IVF. Prospective studies will strengthen its validity among different ethnic populations.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>

    
</article>

